An oral vaccine reduced infection risk in a trial where people were deliberately exposed to high doses of norovirus, and ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

A total of 3 700 Namibians succumbed to AIDS in 2023, with 2 100 being women and 1 600 men.Acting executive director of health and social welfare policy Axel Tibinyane revealed this at the 19th ...

Nucleoside reverse transcriptase inhibitors -- antiretroviral drugs approved to treat HIV and hepatitis B -- were associated ...

Just two months ago, people living with HIV in Kenya were in distress over a crippling shortage of first-line antiretroviral ...

In an important discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have ...

Expanding access to PrEP is a national public health challenge. But Mississippi is the farthest behind the rest of the ...

Over the past 20 years we have seen great progress in the HIV response; as of 2024 more than 30 million people were accessing antiretroviral treatment, accounting for more than 76 per cent of all ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

President Trump has eliminated funding for programs aimed at ending the growing HIV epidemic among minority communities, ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.